ASP Isotopes (ASPI) Emerging Growth Virtual Conference summary
Event summary combining transcript, slides, and related documents.
Emerging Growth Virtual Conference summary
25 Feb, 2026Conference logistics and introductions
The 90th Emerging Growth Conference is a two-day virtual investor event, with presentations uploaded to YouTube for later viewing.
ASP Isotopes Inc. presented updates as a pre-commercial advanced materials company focused on isotope production for medical, semiconductor, and nuclear energy industries.
Business structure and recent developments
The company operates three subsidiaries: Quantum Leap Energy (nuclear fuels), PET Labs (radioisotopes for oncology), and ASP Isotopes (stable isotopes for semiconductors and medicine).
Plans are underway to spin off Quantum Leap Energy as a separate entity, with an S-1 filed with the SEC.
Recent acquisition of Renergen, a helium supplier, is expected to achieve positive EBITDA after operational improvements.
Technology and production processes
Utilizes Aerodynamic Separation Process (ASP) and Quantum Enrichment (laser-based) for isotope separation, enabling cost-effective, modular, and scalable plant construction.
Plants are environmentally friendly, with no nuclear waste, and are being expanded globally, including plans for new facilities in Iceland.
Latest events from ASP Isotopes
- Helium and isotope production ramp up amid global shortages, with major commercialization by 2026.ASPI
2nd Annual CG Virtual Sustainability Summit12 Mar 2026 - Pursuing global leadership in isotope supply with advanced enrichment tech and strategic expansion.ASPI
Corporate presentation4 Feb 2026 - Ytterbium-176 enrichment achieved; strong cash, plant ramp-up, and growth in isotope demand.ASPI
Q4 20244 Feb 2026 - Expanding isotope production, securing major contracts, and advancing HALEU for nuclear energy.ASPI
Emerging Growth Conference7711 Jan 2026 - Isotope enrichment firm seeks up to $100M in flexible offerings, with $25M at-the-market via Canaccord.ASPI
Registration Filing16 Dec 2025 - Shareholders will vote on director elections, a new equity plan, and auditor ratification at the 2024 meeting.ASPI
Proxy Filing2 Dec 2025 - Annual meeting to elect directors, ratify auditor, and highlight governance and compensation.ASPI
Proxy Filing25 Nov 2025 - Silicon-28 shipment, JSE listing, and Fermi MOU mark key advances in isotope and energy markets.ASPI
Status Update23 Nov 2025 - Q3 2025 delivered strong revenue growth, major contracts, and strategic expansion moves.ASPI
Q3 202521 Nov 2025